The impact of angiotensin converting enzyme inhibitors on the arterial wall

Vascular Medicine

Volumn 1, Issue 2, 1996, Pages 109-113

  Lee, Alison F C ^a   Struthers, Allan D ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

angiotensin converting enzyme inhibitors; angiotensin II; arterial wall; bradykinin; hyperlipidaemia; hypertension

Indexed keywords

CAPTOPRIL; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NIFEDIPINE; PERINDOPRIL; ALDOSTERONE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN I; ANGIOTENSIN II; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRADYKININ; ENDOTHELIN; HYDRALAZINE; LOSARTAN; NITRIC OXIDE; PLATELET DERIVED GROWTH FACTOR; PROPRANOLOL; RAMIPRIL; SARALASIN;

ANTIHYPERTENSIVE ACTIVITY; ARTERIOSCLEROSIS; ARTERY INTIMA PROLIFERATION; BLOOD PRESSURE REGULATION; DRUG EFFECT; ENZYME INHIBITION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; REVIEW; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE; VASODILATATION; ADRENERGIC SYSTEM; AORTA ATHEROSCLEROSIS; ARTERY WALL; ARTICLE; CARDIOVASCULAR MORTALITY; CAROTID ATHEROSCLEROSIS; CLINICAL TRIAL (TOPIC); CORONARY ARTERY ATHEROSCLEROSIS; DRUG EFFICACY; DRUG POTENCY; ENDOTHELIAL DYSFUNCTION; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HIGH RISK POPULATION; MORBIDITY; PROTEIN DEGRADATION; PROTEIN SYNTHESIS INHIBITION; RISK REDUCTION;

EID: 0029762630     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1358863X9600100204     Document Type: Review

References (55)

1. Asmar RG, Pannier B, Santoni JP et al. Reversion of cardiac hypertrophy and reduced arterial compliance after converting enzyme inhibition in essential hypertension. Circulation 1988; 74: 941-50.
2. Opie LH. ACE inhibitors, vascular structure, and arterial disease in hypertension. In: Opie LH ed. Angiotensin converting enzyme inhibitors, second edition. Wiley-Liss, New York; 1995: 240-65.
3. Drexler H. Effect of angiotensin-converting enzyme inhibitors on the peripheral circulation in heart failure. Am J Cardiol 1992; 70: 50C-54C.
4. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 293-301.
5. Benetos A, Santoni JP, Safar ME. Vascular effects of intravenous infusion of the angiotensin converting enzyme inhibitor perindopril. J Hypertens 1990; 8: 818-26.
6. Clozel JP, Kuhn H, Hefti F. Effects of cilazapril on the cerebral circulation in spontaneously hypertensive rats. Hypertension 1989; 14: 645-51.
7. Creager MA, Roddy M-A. Effect of captopril and enalapril on endothelial function in hypertensive patients. Hypertension 1994; 24: 499-505.
8. Dzau VJ, Safar ME. Large conduit arteries in hypertension: role of the vacular renin angiotensin system. Circulation 1988; 77: 947-54.
9. Chobian AV, Haudenschild CC, Nicherson C, Drago R. Anti atherogenic effect of captopril in the watanabe heritable hyperlipidaemic rabbit. Hypertension 1990; 15: 327-31.
10. Lee RMKW, Berecek KH, Tsoporis J et al. Prevention of hypertension and vascular changes by captopril treatment. Hypertension 1991; 17: 141-50.
11. Lindop GBM, Dargie JH. Cardiovascular system. In: Mac Sween RNM, Whaley K eds. Muirs textbook of pathology, thirteenth edition. London: Edward Arnold, 1992: 440-523.
12. Golke P, Lamberty V, Kuwer I et al. Vascular remodeling in systemic hypertension. Am J Cardiol 1993; 71: 2E-7E.
13. Levy BI, Michel JB, Salzmann JL et al. Long term effects of angiotensin-converting enzyme inhibition on the arterial wall of adult spontaneously hypertensive rats. Am J Cardiol 1993; 71: 8E-16E.
14. Richer C, Thuillez C, Guidicelli JF. Perindopril, converting enzyme blockade, and peripheral arterial hemodynamics in the healthy volunteer. J Cardiovasc Pharmacol 1987; 9: 94-102.
15. Wolinsky H. Response of rat aortic media to hypertension. Circ Res 1970; 26: 507-22.
16. Harrap SB, Mitchell GA, Casley DJ et al. Angiotensin-II, sodium and cardiovascular hypertrophy in spontaneously hypertensive rats. Hypertension 1993; 21: 50-55.
17. Bund SJ, West KP, Heagerty AM. Effects of protection from pressure on resistance artery morphology and reactivity in spontaneously hypertensive and Wistar-Kyoto rats. Cir Res 1991; 68: 1230-40.
18. Owens GK. Influence of blood pressure on development of aortic smooth muscle hypertrophy in spontaneously hypertensive rats. Hypertension 1987; 9: 178-87.
19. Hajdu MA, Heistad DD, Baumbach GL. Effects of antihypertensive therapy on mechanics of cerebral arterioles in rats. Hypertension 1991; 17: 308-16.
20. Wang D-H, Prewitt RL. Captopril reduces aortic and microvascular growth in hypertensive and normotensive rats. Hypertension 1990; 15: 68-77.
21. Christensen KL, Jespersen LT, Mulvaney MJ. Development of blood pressure in spontaneously hypertensive rats after withdrawal of longterm treatment related to vascular structure. Hypertension 1989; 14: 645-51.
22. Pepine CJ. Angiotensin converting enzyme inhibition and coronary artery disease. J Hypertens 1994; 12(4): S65-S71.
23. Black MJ, Campbell JH, Campbell GR. Effect of perindopril on cardiovascular hypertrophy of the SUR: respective roles of reduced blood pressure and reduced angiotensin II levels. Am J Cardiol 1993; 71: 17E-21E.
24. Gilligan DM, Guetta V, Panza JA, Garcia CE, Quyyami AA, Cannon RO. Selective loss of microvascular endothelial function in human hypercholesterolaemia. Circulation 1994; 90: 35-41.
25. Zeiher AM, Drexler H, Wollschlager H, Just H. Modulation of coronary vasomotor tone in humans. Circulation 1991; 83(2): 391-101.
26. Casino PR, Kilcoyne CM, Quyyami AA, Hoeg JM, Panza MD. The role of nitric oxide in endothelial dependent vasodilatation of the hypercholesterolaemic patient. Circulation 1993; 88: 2541-47.
27. Decker RHA, Wiemer G, Linz W. Preservation of endothelial function by ramipril in rabbits on a long-term atherogenic diet. J Cardiovas Pharmacol 1991; 18(2): S110-S115.
28. Shah BR, Blehm DJ, Frierdich GE, McMahon EG, Blaine EH. Differential effects of renin angiotensin system blockade on atherogenesis in cholesterol fed rabbits. J Clin Invest 1993; 91: 1453-58.
29. Aberg G, Ferrer P. Effects of captopril and atherosclerosis in cynomolgus monkeys. J Cardiovasc Pharmaacol 1990; 15(5): S65-S72.
30. Harrison DG, Armstrong ML, Freiman PC, Heistad DD. Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis. J Clin Invest 1987; 80: 1808-11.
31. Powell JS, Clozel JP, Muller RKM et al. Inhibitors of angiotensin converting enzyme prevent myointimal proliferation after vascular injury. Science 1989; 245: 186-88.
32. Daemen MJAP, Lombardi DM, Bosman FT, Schwartz SM. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res 1991; 68: 450-56.
33. The Multicentre European Research trial with Cilazapril after Angioplasty to prevent Transluminal coronary Obstruction and Restenosis (MERCATOR) Study Group. Does the new angiotensin converting enzyme inhibitor prevent restenosis after percutaneous transluminal coronary angioplasty? Circulation 1992; 86: 100-10.
34. Carbonell LF, Carretero OA, Stewart JM, Scicli AG. Effect of a kinin antagonist on the acute antihypertensive activity of enalaprilat in severe hypertension. Hypertension 1988; 11: 239-43.
35. Kato H, Suzuki H, Tajima S et al. Angiotensin II stimulates collagen synthesis in vascular smooth muscle cells. J Hypertens 1991; 9: 17-22.
36. Zimmerman BG. Adrenergic facilitation by angiotensin: does it serve a physiological function? Clin Sci 1981; 60: 343-48.
37. Lee RMKW, Triggle CR, Cheung DWT, Coughlin MD. Structural and functional consequences of neonatal sympathectomy on the blood vessels of spontaneously hypertensive rats. Hypertension 1987; 10: 328-38.
38. Eccleston-Joyner CA, Gray SD. Arterial hypertrophy in the fetal and neonatal spontaneously hypertensive rat. Hypertension 1988; 12: 513-18.
39. Yamouri Y, Tarazi RC, Ooshima A. Effect of β-receptor-blocking agents on cardiovascular structural changes in spontaneous and noradrenaline induced hypertension in rats. Clin Sci 1980; 59: 457-60.
40. Panza JA, Quyyumi AA, Brush JE, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22-27.
41. Clozel M, Kuhn H, Baumgartner HR. ACE inhibition and the vascular intima in hypertension. J Cardiovas Pharmacol 1993; 22(4): S15-S18.
42. Mombouli J-V, Nephtali M, Vanhoutte PM. Effects of the converting enzyme inhibitor cilazaprilat on endothelium-dependent responses. Hypertension 1991; 18(11): II-22-II-29.
43. Dzau VJ, Gibbons GH, Pratt RE. Molecular mechanisms of vascular renin angiotensin system in myointimal hyperplasia. Hypertension 1991; 18: II-100-II-105.
44. Cachofeiro V, Sakakibara T, Nasjletti A. Kinins, nitric oxide, and the hypotensive effect of captopril and ramiprilat in hypertension. Hypertension 1992; 19: 138-45.
45. Farhy RD, Carretcro OA, Ho K-L, Scicli AG. Role of kinins and nitric oxide in the effects of angiotensin-converting enzyme inhibitors on neointima formation. Circ Res 1993; 72: 1202-10.
46. Safar ME, Toto-Moukouo JJ, Bouthier JA et al. Arterial dynamics, cardiac hypertrophy, and antihypertensive treatment. Circulation 1987; 75: I-156-I-161.
47. Geistefer AAT, Peach MJ, Owens GK. Angiotensin II induces hypertrophy, not hyperplasia, of cultured aortic smooth muscle cells. Circ Res 1988; 62: 749-56.
48. Schelling P, Fischer H, Ganten D. Angiotensin and cell growth: a link to cardiovascular hypertrophy? J Hypertens 1991; 9: 3-15.
49. Vanhouette PM. Is endothelin involved in the pathogenesis of hypertension? Hypertension 1993; 21: 747-51.
50. Paquet JL, Bandomin Legros M, Brunelle G, Meyer R. Angiotensin II induced proliferation of aortic myocytes in spontaneously hypertensive rats. J Hypertens 1990; 8: 565-72.
51. Dzau VJ, Pratt R, Gibbons G, Schumbert H, Lorell B, Ingelfinger J. Molecular mechanisms of angiotensin in the regulation of vascular growth. J Mol Cell Cardiol 1989; 21(suppl II): S438-S441.
52. Black MJ, Adams MA, Bobik A et al. Effects of enalapril on aortic smooth muscle cell polyploidy in the spontaneously hypertensive rat. J Hypertens 1989; 7: 997-1003.
53. Moalic JM, Bauters C, Himbert D et al. Phenylephrine, vasopressin and angiotensin II as determinants of protooncogene and heat shock protein gene expression in adult rat heart and aorta. J Hypertens 1989; 7: 195-201.
54. Lyall F, Deehan MR, Greer IA et al. Mechanical stretch increases proto-oncogene expression and phosphoinositide turnover in vascular smooth muscle cells. J Hypertens 1994; 12: 1139-45.
55. Ohya Y, Sperelakis N. Involvement of a GTP-binding protein in stimulating action of angiotensin-II on calcium channels in vascular smooth muscle cells. Circ Res 1991; 68: 763-71.